Cider Xie
About Cider Xie
Cider Xie is a Senior Sales Representative at Bristol-Myers Squibb in New York, with over a decade of experience in the pharmaceutical industry, including roles at Pfizer and Fosun Capital.
Current Position at Bristol-Myers Squibb
Cider Xie is currently employed as a Senior Sales Representative at Bristol-Myers Squibb in New York, New York, United States. Cider has been with the company since December 2012, showcasing a decade-long tenure in this role. This position involves complex sales-related responsibilities, indicating extended experience in the pharmaceutical sales industry.
Previous Experience at Pfizer
Before joining Bristol-Myers Squibb, Cider Xie worked at Pfizer in Shanghai, China. Cider held the position of National Sales Assistant from 2010 to 2011 for 10 months, followed by a role as a Medical Information Communication Specialist from 2011 to 2012 for 1 year. These roles provided valuable experience in sales and medical communication within the pharmaceutical sector.
Business Development at Fosun Capital
Cider Xie worked at Fosun Capital from 2009 to 2010 as an Assistant and Analyst for Business Development. This role allowed Cider to gain insight into business development strategies, contributing to a diverse professional background that complements their sales expertise in the pharmaceutical industry.
Education at China Pharmaceutical University
Cider Xie studied at China Pharmaceutical University and earned a bachelor's degree. The academic tenure lasted from 2005 to 2009, covering a span of 4 years. This educational background provided a strong foundation in pharmaceutical sciences, supporting their subsequent professional roles in the industry.
Experience in Chinese and American Pharmaceutical Markets
Cider Xie has extensive experience in both the Chinese and American pharmaceutical markets. Their career includes significant roles in Shanghai with Pfizer and Fosun Capital, and a long-term position in New York with Bristol-Myers Squibb. This cross-continental exposure has enabled Cider to develop a comprehensive understanding of the global pharmaceutical landscape.